3024611000001103: Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Carteolol\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Carteolol\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\UK product\Trade family\Teoptic\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing carteolol\Carteolol\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing carteolol\Carteolol\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing carteolol\Product containing carteolol in ocular dose form (medicinal product form)\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing carteolol\Carteolol\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing carteolol\Carteolol\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing carteolol\Product containing carteolol in ocular dose form (medicinal product form)\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing carteolol\Carteolol\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing carteolol\Carteolol\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing carteolol\Product containing carteolol in ocular dose form (medicinal product form)\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiglaucoma agent (product)\Product containing carteolol in ocular dose form (medicinal product form)\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as ocular dose form\Product containing carteolol in ocular dose form (medicinal product form)\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing carteolol\Carteolol\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing carteolol\Carteolol\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing carteolol\Product containing carteolol in ocular dose form (medicinal product form)\Product containing only carteolol in ocular dose form (medicinal product form)\Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops\Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17617301000001113 Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

94139101000001110 Teoptic 2% eye drops (Thea Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has unit of administration	drop	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Is a	Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Carteolol hydrochloride	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has unit of administration	drop	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	Drops dose form	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Is a	Teoptic	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has excipient	Benzalkonium chloride	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Carteolol hydrochloride	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has dispensed dose form	Drops dose form	false	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	Conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Has dispensed dose form	Conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd) 5 ml	Is pack of	False	Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd) 5 ml	Has AMP	True	Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17617301000001113	Teoptic 2% eye drops (Novartis Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
94139101000001110	Teoptic 2% eye drops (Thea Pharmaceuticals Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module